Kyorin Holdings Inc
TSE:4569
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Kyorin Holdings Inc
Other Current Liabilities
Kyorin Holdings Inc
Other Current Liabilities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Liabilities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Kyorin Holdings Inc
TSE:4569
|
Other Current Liabilities
¥10.6B
|
CAGR 3-Years
0%
|
CAGR 5-Years
2%
|
CAGR 10-Years
0%
|
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Other Current Liabilities
¥1.6T
|
CAGR 3-Years
2%
|
CAGR 5-Years
5%
|
CAGR 10-Years
8%
|
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Other Current Liabilities
¥209.7B
|
CAGR 3-Years
54%
|
CAGR 5-Years
32%
|
CAGR 10-Years
16%
|
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Other Current Liabilities
¥560.1B
|
CAGR 3-Years
24%
|
CAGR 5-Years
22%
|
CAGR 10-Years
8%
|
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Other Current Liabilities
¥220.4B
|
CAGR 3-Years
2%
|
CAGR 5-Years
14%
|
CAGR 10-Years
15%
|
|
|
Astellas Pharma Inc
TSE:4503
|
Other Current Liabilities
¥737.4B
|
CAGR 3-Years
24%
|
CAGR 5-Years
17%
|
CAGR 10-Years
14%
|
|
Kyorin Holdings Inc
Glance View
KYORIN Holdings, Inc. engages in the development, manufacture and sale of pharmaceutical products through its subsidiaries. The company is headquartered in Chiyoda-Ku, Tokyo-To and currently employs 2,243 full-time employees. The company went IPO on 2006-03-10. The firm operates through two business segments. The Pharmaceuticals segment is engaged in the manufacture, purchase and sales of pharmaceutical products, the evaluation of technologies, the inspection, analysis and negotiation of license affiliations, as well as the research of new drugs and candidate compounds. The company also engages in the purchase and sales of medical promotion tools and packaging materials. The Healthcare segment is engaged in the manufacturing, sales and purchase of environmental sanitation products, general purpose medicines and skin care products.
See Also
What is Kyorin Holdings Inc's Other Current Liabilities?
Other Current Liabilities
10.6B
JPY
Based on the financial report for Dec 31, 2025, Kyorin Holdings Inc's Other Current Liabilities amounts to 10.6B JPY.
What is Kyorin Holdings Inc's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
0%
Over the last year, the Other Current Liabilities growth was 6%.
